Physician

Rulx Ganthier, M.D.

According to 2025 Medicare claims, Rulx Ganthier, M.D. (NPI: 1366540817) practices ophthalmology in the Sebring, FL market, with the plurality of this provider's patient population coming from Highlands, FL. This provider's primary affiliated billing organization is HIGHLANDS EYE INSTITUTE PA (NPI: 1861590309; TIN: 20-2076730) and primary practice location at 33870-2173.

Ganthier's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 641 traditional Medicare patients, billed 4,843 HCPCS/CPT codes, and received $295,235 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,440 prescription claims across 530 beneficiaries totaling $244,773 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 5 records totaling $88. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $528,731 to $295,235. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$283K$566K2015 Medicare payment: $528,731 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $565,831 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $527,019 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $512,827 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $476,489 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $400,942 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $392,432 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $346,892 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $316,428 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $295,235 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159206,952$528,731
20169307,389$565,831
20179057,846$527,019
20188848,067$512,827
20198617,454$476,489
20208026,255$400,942
20217856,408$392,432
20227395,917$346,892
20236915,397$316,428
20246414,843$295,235

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$134K$268K2015 Drug cost: $162,296 (USD; Tot_Drug_Cst)2016 Drug cost: $179,884 (USD; Tot_Drug_Cst)2017 Drug cost: $188,500 (USD; Tot_Drug_Cst)2018 Drug cost: $209,831 (USD; Tot_Drug_Cst)2019 Drug cost: $227,150 (USD; Tot_Drug_Cst)2020 Drug cost: $218,051 (USD; Tot_Drug_Cst)2021 Drug cost: $248,742 (USD; Tot_Drug_Cst)2022 Drug cost: $267,875 (USD; Tot_Drug_Cst)2023 Drug cost: $243,802 (USD; Tot_Drug_Cst)2024 Drug cost: $244,773 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154021,764$162,296
20164141,800$179,884
20174041,626$188,500
20183961,727$209,831
20194301,959$227,150
20204742,304$218,051
20215492,520$248,742
20225012,411$267,875
20235122,344$243,802
20245302,440$244,773

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more537879$93
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more358678$68
92083Exam of visual field with extended testing275290$46
92134Imaging of retina562934$29
92250Photography of the retina527529$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine523,315$64,297
XiidraLifitegrast291,440$31,634
LumiganBimatoprost453,408$28,711
TravoprostTravoprost794,039$15,268
RhopressaNetarsudil Mesylate271,362$13,793

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$88Notal Vision, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rulx Ganthier, M.D.?

Tedicare shows public-source Medicare data for Rulx Ganthier, M.D. (NPI 1366540817), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rulx Ganthier, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rulx Ganthier, M.D.?

Rulx Ganthier, M.D. is linked to HIGHLANDS EYE INSTITUTE PA (billing NPI 1861590309) in the available physician profile data.

Does Rulx Ganthier, M.D. have Open Payments data?

Rulx Ganthier, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.